Q4 2016 Holdings
Filed 2017-02-14 | 70 holdings | $33.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Boston Scientific Corp(BSX) | COM | 101137107 | $9.7M | 450,000 | 28.9% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $7.3M | 1,150,000 | 21.6% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $5.8M | 140,000 | 17.4% |
| Biogen Inc(BIIB) | COM | 09062X103 | $4.3M | 15,000 | 12.6% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $3.3M | 120,000 | 9.7% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $2.9M | 100,000 | 8.6% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $35.5K | 600,000 | 0.1% |
| Shire PLC | SPONSORED ADR | 82481R106 | $17.0K | 100,000 | 0.1% |
| Abbott Labs(ABT) | COM | 002824100 | $15.4K | 400,000 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $14.1K | 115,000 | 0.0% |
| Zimmer Biomet Hldgs Inc(ZBH) | COM | 98956P102 | $13.4K | 130,000 | 0.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $13.2K | 225,000 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $12.7K | 110,000 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $11.4K | 325,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $10.2K | 200,000 | 0.0% |
| Nuvasive Inc(NUVAGBP) | COM | 670704105 | $10.1K | 150,000 | 0.0% |
| Acadia Pharmaceuticals Inc(ACAD)Call | COM | 004225108 | $10.1K | 350,000 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $9.8K | 220,000 | 0.0% |
| Bristol Myers Squibb Co(BMY)Call | COM | 110122108 | $8.8K | 150,000 | 0.0% |
| Avexis Inc | COM | 05366U100 | $8.4K | 175,000 | 0.0% |
| Spectranetics Corp | COM | 84760C107 | $8.2K | 335,000 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $7.9K | 150,000 | 0.0% |
| Abbott Labs(ABT)Call | COM | 002824100 | $7.7K | 200,000 | 0.0% |
| Intercept Pharmaceuticals in(ICPTUSD) | COM | 45845P108 | $7.6K | 70,000 | 0.0% |
| Neuroderm LTD | ORD SHS | M74231107 | $7.3K | 330,000 | 0.0% |
| Glaukos Corp(GKOS) | COM | 377322102 | $6.9K | 200,000 | 0.0% |
| Lion Biotechnologies Inc | COM | 53619R102 | $6.8K | 975,000 | 0.0% |
| Mallinckrodt PUB LTD Co | SHS | G5785G107 | $6.7K | 135,000 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $6.6K | 175,000 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $6.5K | 90,000 | 0.0% |
| Boston Scientific Corp(BSX)Call | COM | 101137107 | $6.5K | 300,000 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $6.2K | 1,700,000 | 0.0% |
| Puma Biotechnology Inc(PBYI)Call | COM | 74587V107 | $6.1K | 200,000 | 0.0% |
| Flamel Technologies SA | SPONSORED ADR | 338488109 | $6.0K | 575,000 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $5.8K | 100,000 | 0.0% |
| Perrigo Co PLC(PRGO) | SHS | G97822103 | $5.8K | 70,000 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $5.7K | 475,000 | 0.0% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $5.6K | 250,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT)Call | COM | 803607100 | $5.5K | 200,000 | 0.0% |
| Currencyshares Swiss Franc T | SWISS FRANC SH | 23129V109 | $4.3K | 46,400 | 0.0% |
| Endo Intl PLC | SHS | G30401106 | $4.1K | 250,000 | 0.0% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $4.1K | 365,000 | 0.0% |
| Wright MED Group N V | ORD SHS 0.03 PAR | N96617118 | $4.0K | 175,000 | 0.0% |
| Spark Therapeutics Inc | COM | 84652J103 | $4.0K | 80,000 | 0.0% |
| Entellus MED Inc | COM | 29363K105 | $3.8K | 200,000 | 0.0% |
| Qiagen NV(QGEN) | REG SHS | N72482107 | $3.8K | 135,000 | 0.0% |
| Aquinox Pharmaceuticals Inc | COM | 03842B101 | $3.7K | 225,000 | 0.0% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $3.5K | 115,182 | 0.0% |
| Iridex Corp(IRIX) | COM | 462684101 | $2.8K | 200,000 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $2.7K | 225,000 | 0.0% |